MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online

    F. Luna-Rangel, H. Martinez, O. Gutierrez-Treviño, C. Armengol-Garcia, J. Luna, B. Perez Martinez, J. Figueroa-Sanchez (San Pedro, Mexico)

    Objective: To investigate the association between occupational solvent exposure and Parkinson’s disease using data from the PPMI Online cohort. Background: Environmental toxicant exposure has been…
  • 2026 International Congress

    Impact of Variants in ADH1B and ALDH2 on Parkinson’s Disease in Japan

    M. Kinoshita, H. Ohara, R. Sasaki, K. Tamura, M. Iyer, B. Vellingiri (Kyoto, Japan)

    Objective: We analyzed the relationship among prevalence of Parkinson’s disease, the variants in ADH1B and ALDH2, alcohol consumption and smoking per population among Japanese prefectures.…
  • 2026 International Congress

    The Impact of Dopamine-Induced Impulse Control Disorders on Quality of Life in Young-Onset Parkinson’s Disease

    S. Pokhriyal, A. Gupta (Delhi, India)

    Objective: To quantify how impulse control disorders (ICDs) alter day-to-day functionality and overall quality of life (QoL) among individuals living with Young-Onset Parkinson’s Disease (YOPD),…
  • 2026 International Congress

    Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis

    I. Serag, A. Negida (Mansoura, Egypt)

    Objective: To systematically map and quantitatively synthesize evidence on ECG-derived markers associated with autonomic dysfunction in PD and evaluate their ability to differentiate patients from…
  • 2026 International Congress

    Huntington’s Disease Genetic Testing Practices in the Lower North Island of New Zealand

    D. Llewelyn, D. Bourke (Wellington, New Zealand)

    Objective: This audit reviewed Huntington’s Disease (HD) diagnostic and predictive testing in New Zealand’s lower North Island. Key objectives included evaluating the frequency of pre-test…
  • 2026 International Congress

    Mild Motor Impairments in Rapid Eye Movement Behavior Disorder: Tremor and Bradykinesia

    JH. Lee, ER. Tobin, EA. Christou, XY. Lou, M. Louis, LH. Le, MF. Presti, MS. Jaffee, DE. Vaillancourt (Gainesville, USA)

    Objective: We investigated patients with RBD to identify mild motor impairments through the objective quantification of sensitive motor control assays. Background: It is established that…
  • 2026 International Congress

    Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort and Mendelian randomization Study

    L. Li, Z. Zhong, L. Liu (shanghai, China)

    Objective: This study aims to investigate the causal relationship between disruptions in sleep circadian rhythms and the risk of seven brain disorders. Background: Disruptions in…
  • 2026 International Congress

    Community Gym Exercise Therapy for People Living with Early Onset Parkinson’s Disease

    C. Thwaites, M. Morris, D. Harris, M. Callisaya, R. Mouer, A. Clifford (Bundoora, Australia)

    Objective: To understand the experiences of people living with early onset Parkinson’s disease (EOPD) and exercise trainers regarding the safety, feasibility, acceptability and perceived benefits…
  • 2026 International Congress

    Risk factors for dysautonomic fluctuations in Mexican PwP

    MF. Medina-Pérez, MF. Velasco-Delgado, A. Cervantes-Arriaga, R. Solís-Vivanco, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…
  • 2026 International Congress

    Effectiveness and Safety of Deutetrabenazine in Chinese Patients with Huntington’s Disease-associated Chorea: A Multicenter Phase 4 Study

    Y. Cheng, Y. Huang, J. Ma, J. Yin, X. Dan, J. Qu, Y. Li, G. Zhang, KT. Ustundag, AP. Levin, R. Ribalov, H. Xie, R. Eshet, M. Zeygarnik, J. Wang, H. Shang (Chengdu, China)

    Objective: To evaluate the effectiveness and safety of deutetrabenazine (DTBZ) in Chinese patients with Huntington’s Disease (HD)-associated chorea. Background: Chorea is a key symptom of…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley